An experimental personalized mRNA cancer vaccine has successfully prevented melanoma from returning in a large Phase 3 ...
In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to ...
A new study published in Science Translational Medicine has demonstrated a new mechanism by which mRNA COVID vaccines can cause heart inflammation, or myocarditis, in young men. While rare, ...
The cardiomyositis that is a rare adverse effect of mRNA-based COVID vaccines is due to immune cell activity as a result of increased levels of the chemokines CXCL10 and interferon-γ (IFN-γ). Blocking ...
In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to ...
IFLScience on MSN
For the first time ever, a personalized mRNA cancer vaccine has cleared phase 3 trials – and with flying colors
It took a long time – and a deadly global pandemic – for mRNA vaccines to go from promising research curio to routine ...
mRNA cancer vaccine Phase 3 win: Merck and Moderna announced August 19 that intismeran autogene cut melanoma recurrence risk ...
Five years of mass deployment. Billions of administered doses. A political environment that twice nearly defunded the research. And now, the most comprehensive scientific accounting the platform has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results